Inhibition of angiogenesis: thalidomide or low-molecular-weight heparin?
Ozkan
Metin
M
Eser
Bulent
B
Er
Ozlem
O
Dogu
Gamze Gokoz
GG
Altinbas
Mustafa
M
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000925:Anticoagulants / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009389:Neovascularization, Pathologic / Q000517:prevention & control*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D013792:Thalidomide / Q000627:therapeutic use*
D020533:Angiogenesis Inhibitors; D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D013792:Thalidomide